Telomir Pharmaceuticals (TELO US)

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The Company focuses on the development and commercialization of telomir 1, a novel treatment that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer. Telomir Pharmaceuticals serves customers in the United States.